Recent clinical history and cognitive dysfunction for attention and executive function among human immunodeficiency virus-infected patients

Archives of Clinical Neuropsychology

Volumn 26, Issue 7, 2011, Pages 614-623

  Tate, David F ^a,b,g   DeLong, Allison ^c   McCaffrey, Daniel E ^a   Kertesz, Kinga ^a   Paul, Robert H ^d   Conley, Jared ^a   Russell, Troy ^a   Coop, Kathleen ^e   Gillani, Fizza ^a   Flanigan, Timothy ^e,f   Tashima, Karen ^e,f   Hogan, Joseph W ^c,e  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^c BROWN UNIVERSITY   (United States)

^d UNIVERSITY OF MISSOURI ST LOUIS   (United States)

^e Center for AIDS Research   (United States)

^f BROWN UNIVERSITY   (United States)

^g BROOKE ARMY MEDICAL CENTER   (United States)

Author keywords

Cognition; Executive function; HIV; Neuropsychology; Recent clinical history

Indexed keywords

EID: 80855123920     PISSN: 08876177     EISSN: 18735843     Source Type: Journal    
DOI: 10.1093/arclin/acr065     Document Type: Article

References (47)

1. Ances, B. M., & Ellis, R. J. (2007). Dementia and neurocognitive disorders due to HIV-1 infection. Seminars in Neurology, 27(1), 86-92. (Pubitemid 46239043)
2. Baddeley, A, Emslie, H, & Nimmo-Smith, I. (1993). The Spot-the-Word test: A robust estimate of verbal intelligence based on lexical decision. Br J Clin Psychol. 32(Pt 1): 55-65. (Pubitemid 23087722)
3. Bornstein, R. A., Nasrallah, H. A., Para, M. F., Fass, R. J., Whitacre, C. C., & Rice, R. R., Jr. (1991). Rate of CD4 decline and neuropsychological performance in HIV infection. Archives of Neurology, 48, 704-707.
4. Brew, B. J. (2004). Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex. AIDS, 18(Suppl. 1), S75-S78. (Pubitemid 38365909)
5. Brew, B. J., Pemberton, L., Cunningham, P., & Law, M. G. (1997). Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. Journal of Infectious Diseases, 175(4), 963-966. (Pubitemid 27142978)
6. Bycott, P., & Taylor, J. (1998). A comparison of smoothing techniques for CD4 data measured with error in a time-dependent Cox proportional hazards model. Stat Med. 17(18), 2061-2077. (Pubitemid 28442015)
7. Cameron, D. W., Heath-Chiozzi, M., Danner, S., Cohen, C., Kravcik, S., Maurath, C., et al. (1998). Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study Group. Lancet, 351(9102), 543-549. (Pubitemid 28077559)
8. Childs, E. A., Lyles, R. H., Selnes, O. A., Chen, B., Miller, E. N., Cohen, B. A., et al. (1999). Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology, 52(3), 607-613. (Pubitemid 29075612)
9. Dore, G. J., Hoy, J. F., Mallal, S. A., Li, Y., Mijch, A. M., French, M. A., et al. (1997). Trends in incidence of AIDS illnesses in Australia from 1983 to 1994: The Australian AIDS cohort. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology, 16(1), 39-43.
10. Egger, M., Hirschel, B., Francioli, P., Sudre, P., Wirz, M., Flepp, M., et al. (1997). Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: Prospective multicentre study. Swiss HIV Cohort Study. British Medical Journal, 315(7117), 1194-1199. (Pubitemid 27478210)
11. Ferrando, S., van Gorp, W., McElhiney, M., Goggin, K., Sewell, M., & Rabkin, J. (1998). Highly active antiretroviral treatment in HIV infection: Benefits for neuropsychological function. AIDS, 12(8), F65-F70. (Pubitemid 28241393)
12. Hammer, S. M., Squires, K. E., Hughes, M. D., Grimes, J. M., Demeter, L. M., Currier, J. S., et al. (1997). A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. New England Journal of Medicine, 337(11), 725-733. (Pubitemid 27417971)
13. Heaton, R. K., Grant, I., Butters, N., White, D. A., Kirson, D., Atkinson, J. H., et al. (1995). The HNRC 500-neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. Journal of the International Neuropsychological Society, 1(3), 231-251.
14. Heaton, R. K., Marcotte, T. D., Mindt, M. R., Sadek, J., Moore, D. J., Bentley, H., et al. (2004). The impact of HIV-associated neuropsychological impairment on everyday functioning. Journal of the International Neuropsychological Society, 10(3), 317-331. (Pubitemid 38779804)
15. Hinkin, C. H., Castellon, S. A., Durvasula, R. S., Hardy, D. J., Lam, M. N., Mason, K. I., et al. (2002). Medication adherence among HIV+ adults: Effects of cognitive dysfunction and regimen complexity. Neurology, 59(12), 1944-1950. (Pubitemid 36076569)
16. Hinkin, C. H., Hardy, D. J., Mason, K. I., Castellon, S. A., Durvasula, R. S., Lam, M. N., et al. (2004). Medication adherence in HIV-infected adults: Effect of patient age, cognitive status, and substance abuse. AIDS, 18(Suppl. 1), S19-S25. (Pubitemid 38365902)
17. Honaker, J. H., King, G., & Blackwell, M. (2009). Amelia II: A program for missing data. R package version 1.2-13. http://CRAN.R-project.org/ package=Amelia.
18. Ickovics, J. R., Hamburger, M. E., Vlahov, D., Schoenbaum, E. E., Schuman, P., Boland, R. J., et al. (2001). Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: Longitudinal analysis from the HIV Epidemiology Research Study. JAMA, 285(11), 1466-1474.
19. Kaplan, J. E., Hanson, D., Dworkin, M. S., Frederick, T., Bertolli, J., Lindegren, M. L., et al. (2000). Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clinical Infectious Diseases, 30(Suppl. 1), S5-S14.
20. Kellogg, S. H., McHugh, P. F., Bell, K., Schluger, J. H., Schluger, R. P., LaForge, K. S., et al. (2003). The Kreek-McHugh-Schluger-Kellogg scale: A new, rapid method for quantifying substance abuse and its possible applications. Drug and Alcohol Dependence, 69, 137-150. (Pubitemid 36259776)
21. Kusdra, L., McGuire, D., & Pulliam, L. (2002). Changes in monocyte/macrophage neurotoxicity in the era of HAART: Implications for HIV-associated dementia. AIDS, 16(1), 31-38. (Pubitemid 34062179)
22. Laird, N., Donnelly, C., & Ware, J. H. (1992). Longitudinal studies with continuous response. Statistical Methods in Medical Research, 1, 3-25.
23. Levy, R., & Bredesen, D. (1988). Central nervous system dysfunction in acquired immunodeficiency syndrome. Journal of Acquired Immune Deficiency Syndromes, 1, 41.
24. Little, R. J. A., & Rubin, D. B. (2002). Statistical analysis with missing data (2nd ed.). Wiley Series in Probability and Statistics. Hoboken, NJ: John Wiley & Sons, Inc.
25. Marcotte, T. D., Heaton, R. K., Wolfson, T., Taylor, M. J., Alhassoon, O., Arfaa, K., et al. (1999). The impact of HIV-related neuropsychological dysfunction on driving behavior. The HNRC Group. Journal of the International Neuropsychological Society, 5(7), 579-592. (Pubitemid 30047684)
26. McArthur, J. C., Brew, B. J., & Nath, A. (2005). Neurological complications of HIV infection. Lancet Neurology, 4(9), 543-555. (Pubitemid 41139976)
27. McArthur, J., Haughey, N., Gartner, S. Contant, K., Pardo, C., Nath, A., et al. (2003). Human immunodeficiency virus-associated dementia: An evolving disease. Journal of Neurovirology, 9, 205-221. (Pubitemid 36656454)
28. McArthur, J. C., McClernon, D. R., Cronin, M. F., Nance-Sproson, T. E., Saah, A. J., St Clair, M., et al. (1997). Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain. Annals of Neurology, 42(5), 689-698. (Pubitemid 27481540)
29. McArthur, J. C., McDermott, M. P., McClernon, D., St Hillaire, C., Conant, K., Marder, K., et al. (2004). Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy. Archives of Neurology, 61(11), 1687-1696. (Pubitemid 39463427)
30. McCutchan, J. A., Wu, J. W., Robertson, K., Koletar, S. Ld, Ellis, R. Ja., Cohn, S., et al. (2007). HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients. AIDS, 21, 1109-1117. (Pubitemid 46763281)
31. Mellors, J. W., Munoz, A., Giorgi, J. V., Margolick, J. B., Tassoni, C. J., Gupta, P., et al. (1997). Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Annals of International Medicine, 126(12), 946-954. (Pubitemid 27255797)
32. Montaner, J. S., Reiss, P., Cooper, D., Vella, S., Harris, M., Conway, B., et al. (1998). A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: The INCAS Trial. Italy, The Netherlands, Canada and Australia Study. JAMA, 279(12), 930-937. (Pubitemid 28136082)
33. Navia, B., Cho, E., Petito, C., & Price, R. (1986). The AIDS dementia complex: II neuropathology. Annals of Neurology, 19, 525-535.
34. Navia, B., & Price, R. (1987). The acquired immunodeficiency syndrome dementia complex as the presenting or sole manifestation of human immunodeficiency virus infection. Archives of Neurology, 44, 65.
35. Paul, R. H., Lawrence, J., Williams, L. M., Richard, C. C., Cooper, N., & Gordon, E. (2005). Preliminary validity of "integneuro": A new computerized battery of neurocognitive tests. International Journal of Neuroscience, 115(11), 1549-1567. (Pubitemid 41634356)
36. R Development Core Team. (2009). R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing. ISBN 3-900051-07-0, http://www.R-project.org.
37. Robertson, K. R., Robertson, W. T., Ford, S., Watson, D., Fiscus, S., Harp, A. G., et al. (2004). Highly active antiretroviral therapy improves neurocognitive functioning. Journal of Acquired Immune Deficiency Syndromes, 36(1), 562-566. (Pubitemid 38544504)
38. Robertson, K. R., Smurzynski, M., Parsons, T. D., Wu, K., Bosch, R. J., Wu, J., et al. (2007). The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS, 21(14), 1915-1921. (Pubitemid 47329768)
39. Sacktor, N., Lyles, R. H., Skolasky, R., Kleeberger, C., Selnes, O. A., Miller, E. N., et al. (2001). HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology, 56(2), 257-260.
40. Sacktor, N., McDermott, M., Marder, K., Schifitto, G., Selnes, O. A., & McArthur, J. C., et al. (2002). HIV-associated cognitive impairment before and after the advent of combination therapy. Journal of Neurovirology, 8, 136-142. (Pubitemid 34520894)
41. Sacktor, N., Nakasujja, N., Skolasky, R., Robertson, K., Wong, M., Musisi, S., et al. (2006). Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa. Neurology, 67(2), 311-314. (Pubitemid 44305421)
42. Silverstien, S. M., Berten, S., Olson, P., Paul, R., Williams, L. M., Cooper, N., et al. (2007). Development and validation of a World-Wide-Web-based neurocognitive assessment battery: WebNeuro. Behavior Research Methods, 39(4), 940-949.
43. Tate, D. F., Conley, J., Paul, R. H., Coop, K., Zhang, S., Zhou, W., et al.(2010). Quantitative diffusion tensor imaging tractography metrics are associated with cognitive performance in HIV-infected patients. Brain Imaging Behav. 4(1), 68-79.
44. Tozzi, V., Balestra, P., Lorenzini, P., Bellagamba, R., Galgani, S., Corpolongo, A., et al. (2005). Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: Results from an urban observational cohort. Journal of Neurovirology, 11(3), 265-273. (Pubitemid 41122414)
45. Valcour, V., Yee, P., Williams, A.E., Shiramizu, B., Watters, M., Selnes, O., et al. (2006). Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current cognitive and neurological status in human immunodeficiency virus type 1 infection-The Hawaii Aging with HIV Cohort. Journal of Neurovirology, 12(5), 387-391. (Pubitemid 44650051)
46. Villa, G., Solida, A., Moro, E., Tavolozza, M., Antinori, A., & De Luca, A., et al. (1996). Cognitive impairment in asymptomatic stages of HIV infection. A longitudinal study. European Neurology, 36, 125-133.
47. Walsh, K. W. (1985). Understanding brain damage: A primer of neuropsychological evaluation. Edinburgh: Churchill Livingstone.